@EJBrenner_MD @ManasiAgrawalMD @ryanungaro @MichaelKappel12 @JeanFredericCo1 @Siew_C_Ng @gilkaplan @Flaviostein @JamesLewisGIEpi @IOIBD1 @CrohnsColitisFn @NASPGHAN @Y_ECCO_IBD
It is time to close down reporting to the SECURE-IBD database. We are proud of SECURE-IBD’s contributions and incredibly grateful for your help. This initiative was not possible without the support of the entire #IBD community.
covidibd.org
The strength of collaboration!
Study pooling data on TNFi +/- other therapies and #COVID19 outcomes in >6000 patients with immune-mediated inflammatory diseases
@rheum_covid @PsoProtect
Pooled results from @rheum_covid, @SecureIBD, and @PsoProtect, representing >6000 patients with immune-mediated inflammatory disease and #COVID19, support TNFi monotherapy use during the pandemic. @IzadiZara @EJBrenner_MD @JYazdanyMD @MichaelKappel12 ja.ma/3ATO9ZC
New @SecureIBD study from @amandaricciuto at @SickKidsNews IBD Centre: younger patients w.more severe inflammation at-risk for severe #COVID19 (controlling for medications) @gilkaplan @MichaelKappel12 @ManasiAgrawalMD @EJBrenner_MD @ekuenzig @DrNickKennedy academic.oup.com/ecco-jcc/ad…
Our analysis on the impact of #IBD medications in >6000 patients with #COVID19 in our registry is out in @AGA_Gastro!
Impact of Medications on COVID-19 Outcomes in Inflammatory Bowel Disease: Analysis of Over 6,000 Patients from an International Registry. Latest from SECURE-IBD. gastrojournal.org/article/S0…
New GI symptoms in individuals with #IBD who get #COVID19 do not correlate with death or other severe outcomes.
Read our new pub here 👉🏻
academic.oup.com/ibdjournal/…
@ryanungaro @ManasiAgrawalMD @EJBrenner_MD @MichaelKappel12 @JeanFredericCo1
Rajen Parekh, a recent high school graduate, reported on the impact of individual comorbid conditions on #COVID19 outcomes in #IBD @DDS_Journal
What an accomplishment!
pubmed.ncbi.nlm.nih.gov/3418…
@EJBrenner_MD @ryanungaro @ManasiAgrawalMD @JeanFredericCo1 @MichaelKappel12
➡️a reminder to take into account social determinants of health in clinical practice
➡️emphasizes the urgent need for policy change towards equitable healthcare for all
Health is a human right.
NEW GASTROINTESTINAL SYMPTOMS ARE COMMON IN... by @ryanungaro
DDW ePoster Library; May 21 2021; 319648
eposters.ddw.org/ddw/2021/dd…
@EJBrenner_MD @ManasiAgrawalMD @MichaelKappel12 @JeanFredericCo1
COVID-19 OUTCOMES AMONG RACIAL AND ETHNIC... by @EJBrenner_MD
DDW ePoster Library; May 21 2021; 319659
Poster of Distinction!
eposters.ddw.org/ddw/2021/dd…
@ManasiAgrawalMD @ryanungaro @wingyanjoyce @Siew_C_Ng @gilkaplan @JeanFredericCo1 @MichaelKappel12
THE IMPACT OF VEDOLIZUMAB THERAPY ON COVID-19... by @ManasiAgrawalMD
DDW ePoster Library; May 21 2021; 319644
eposters.ddw.org/ddw/2021/dd…
@EJBrenner_MD @ryanungaro @MichaelKappel12 @JeanFredericCo1
THE EFFECTS OF COMORBIDITIES ON COVID-19... by Rajen Parekh
DDW ePoster Library; May 21 2021; 319646
eposters.ddw.org/ddw/2021/dd…
@EJBrenner_MD @MichaelKappel12 @ryanungaro @ManasiAgrawalMD @JeanFredericCo1
Read our paper on VDZ outcomes in #IBD, out in JCC
@Y_ECCO_IBD
👉🏻Compared to all other meds, VDZ use was not a/w hospitalization or severe #COVID19
👉🏻Compared to TNFi monotherapy, VDZ monotherapy was a/w hospitalization, but not severe #COVID19
academic.oup.com/ecco-jcc/ad…
The PREVENT-COVID project here to study #COVID19 vaccination in #IBD!!
Patients, please visit ibdpartners.org/preventcovid and sign up if you're eligible
@CrohnsColitisFn @ryanungaro @MichaelKappel12 @MLongMD @ibddoctor @DrJessicaA
Shoutout to John Sperger, @kushalshah96 and Minxin Lu for developing this great prediction tool and study! We learnt loads from you in the process.
Pre-print on prediction model for adverse #COVID19 outcomes in #IBD patients
@KushalShah93 @EJBrenner_MD @ryanungaro @ManasiAgrawalMD @JeanFredericCo1 @MichaelKappel12 pubmed.ncbi.nlm.nih.gov/3350…
Pre-print on prediction model for adverse #COVID19 outcomes in #IBD patients
@KushalShah93 @EJBrenner_MD @ryanungaro @ManasiAgrawalMD @JeanFredericCo1 @MichaelKappel12 pubmed.ncbi.nlm.nih.gov/3350…
>4000 cases in the SECURE-IBD registry this week and the slope's getting steeper.
ucalgary.maps.arcgis.com/app…
Everyone, please wear a mask, distance, and please get the vaccine when it becomes available to you. Let's end this pandemic together.
Fortunate to get the COVID-19 vaccine today. Amazing triumph of science. This is the beginning of the end of this pandemic. Let’s make 2021 the year we tell COVID to take a hike! @MountSinaiNYC
#COVID19 outcomes in #IBD patients on #tofacitinib
Hot off the press!
pubmed.ncbi.nlm.nih.gov/3332…
@ManasiAgrawalMD @EJBrenner_MD @ryanungaro @MichaelKappel12 @JeanFredericCo1
How are physicians managing #IBD meds in patients with #COVID19?
Our paper to answer this❓is now online!
ncbi.nlm.nih.gov/pmc/article…
@ManasiAgrawalMD @EJBrenner_MD @ryanungaro @MichaelKappel12 @JeanFredericCo1 @Y_ECCO_IBD
We are so excited to announce a Risk Prediction tool based on our data, developed by the amazing modeling experts at UNC Gillings School of Public Health
covidibd.org/covid-19-risk-c…
@kushalshah96 @MichaelKappel12 @EJBrenner_MD @ManasiAgrawalMD @ryanungaro @JeanFredericCo1